Details for New Drug Application (NDA): 020632
✉ Email this page to a colleague
The generic ingredient in MERIDIA is sibutramine hydrochloride. There are six drug master file entries for this compound. Additional details are available on the sibutramine hydrochloride profile page.
Summary for 020632
Tradename: | MERIDIA |
Applicant: | Abbott |
Ingredient: | sibutramine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 22, 1997 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
Approval Date: | Nov 22, 1997 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 15MG | ||||
Approval Date: | Nov 22, 1997 | TE: | RLD: | No |
Expired US Patents for NDA 020632
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-002 | Nov 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-001 | Nov 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
Abbott | MERIDIA | sibutramine hydrochloride | CAPSULE;ORAL | 020632-003 | Nov 22, 1997 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription